Zeto, Inc., a Santa Clara, Calif.-based medical technology company, raised $7.3m in Series A financing.
The round was led by Seraph Group and joined by Aphelion Capital, SV Tech Ventures and Shangbay Capital.
The new capital will be used to accelerate commercialization of its lead product, the zEEG headset and software platform, and develop new products to expand its portfolio.
Led by Aswin Gunasekar, MS, MBA, Chief Executive Officer and Founder, Zeto provides zEEG, a commercially available wireless EEG headset backed by a cloud platform that offers instant upload, tools for analysis and remote interpretation by neurologist. It is approved by the U.S. Food and Drug Administration (FDA) for clinical use.